Short answer · Medically reviewed summary · Last updated: 2026-05-08
Hurler Syndrome (MPS1H) is a severe, progressive lysosomal storage disorder caused by a deficiency of the enzyme alpha-L-iduronidase, which leads to the toxic buildup of complex sugars called glycosaminoglycans (GAGs) in cells throughout the body. This systemic condition affects multiple organ systems, typically presenting in early childhood with developmental delays, skeletal abnormalities, and physical changes, requiring multidisciplinary medical management. What causes Hurler Syndrome (MPS1H)? Hurler Syndrome (MPS1H) is caused by mutations in the IDUA gene.
What is Hurler Syndrome MPS1H
What is Hurler Syndrome MPS1H? Plain-language, medically reviewed definition plus the lived reality told by patients.
Hurler Syndrome (MPS1H) is a severe, progressive lysosomal storage disorder caused by a deficiency of the enzyme alpha-L-iduronidase, which leads to the toxic buildup of complex sugars called glycosaminoglycans (GAGs) in cells throughout the body. This systemic condition affects multiple organ systems, typically presenting in early childhood with developmental delays, skeletal abnormalities, and physical changes, requiring multidisciplinary medical management.
What causes Hurler Syndrome (MPS1H)?
Hurler Syndrome (MPS1H) is caused by mutations in the IDUA gene. Because the body cannot produce enough alpha-L-iduronidase, GAGs accumulate in lysosomes, the "recycling centers" of cells. This buildup interferes with normal cellular function, leading to the multisystem damage characteristic of Hurler Syndrome (MPS1H). It is an autosomal recessive condition, meaning an affected child must inherit one mutated gene copy from each parent.
Which body systems are affected by Hurler Syndrome (MPS1H)?
The accumulation of GAGs causes widespread tissue damage. Common clinical features of Hurler Syndrome (MPS1H) include:
- Skeletal System: Dysostosis multiplex, characterized by abnormal bone growth, joint stiffness, and spinal curvature.
- Neurological: Progressive cognitive impairment and potential hydrocephalus.
- Cardiorespiratory: Enlargement of the heart, valvular disease, and airway obstruction.
- Physical Features: Coarse facial features, enlarged liver and spleen (hepatosplenomegaly), and corneal clouding.
How common is Hurler Syndrome (MPS1H)?
Hurler Syndrome (MPS1H) is the most severe form of Mucopolysaccharidosis type I. The overall incidence of MPS I is estimated to be approximately 1 in 100,000 live births globally. While Hurler Syndrome (MPS1H) is rare, early diagnosis is critical for accessing life-altering therapies like hematopoietic stem cell transplantation (HSCT).
How does MPS1H differ from other MPS disorders?
While all MPS disorders involve GAG storage, Hurler Syndrome (MPS1H) is distinguished by its rapid progression and severe neurological involvement compared to the attenuated forms of MPS I, such as Hurler-Scheie or Scheie syndromes. At DiseaseMaps.org, we currently have 7 community members sharing their experiences with this specific diagnosis.
Next steps
- Consult a metabolic specialist or geneticist to confirm the diagnosis via enzyme assay and genetic testing.
- Connect with the National MPS Society for resources and support.
- Join our community at DiseaseMaps.org to connect with 7 others navigating life with Hurler Syndrome (MPS1H).
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): MPS I
- Orphanet: Hurler syndrome (ORPHA577)
- OMIM (Online Mendelian Inheritance in Man): Mucopolysaccharidosis, Type IH
- National MPS Society: MPS I Disease Information
